2 citations
,
March 2023 in “BioScience Trends” This review discusses the long-term health concerns associated with long COVID, the limitations in current understanding, and suggests future research paths, but reports no new clinical findings.
April 2024 in “Cell death and disease” This review discusses the long-term complications of COVID-19, known as long COVID or PASC, and emphasizes the need to improve awareness and management strategies but reports no new clinical findings.
November 2025 in “Journal of Disease and Public Health” This systematic review found that 5%–10% of COVID-19 cases develop long-term sequelae like neurocognitive impairment and cardiovascular damage, with higher risks in women and severe cases. Vaccination may reduce these risks, but further evidence is needed to confirm its efficacy.
8 citations
,
January 2023 in “Therapeutic Advances in Infectious Disease” January 2021 in “Figshare” This chapter reviews current knowledge on long-term complications after acute COVID-19, differentiating between cardiorespiratory and extra respiratory sequelae, without presenting new clinical findings.